CD274 and neoplasm: Combining CAR-T cells with ICIs and ferroptosis inducers offers a synergistic approach: CAR-T cells target specific tumor antigens, ICIs block inhibitory pathways like PD-1/PD-L1, and ferroptosis inducers promote tumor cell death, enhancing immune infiltration and antitumor activity.